Which hedge funds own INDV? INDIVIOR PHARMACEUTICALS INC, Q2 2026 13F holders
7 of the hedge funds tracked by WhaleCreep disclosed a position in INDV (INDIVIOR PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $283.9m in total. The largest holder by portfolio weight is Melqart at 2.3% of its book. 1 manager opened a new position this quarter: Brevan Howard Capital Management. 1 exited: Rubric Capital Management.
7tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold INDV? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Melqart | Q2 2026 | 2.3% | $24.0m | 585,664 | -14% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $51.3m | 1,250,639 | 1217% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $109.5m | 2,667,827 | -25% | reduced |
| Millennium Management | Q2 2026 | 0.1% | $86.1m | 2,098,945 | -54% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $2.8m | 68,181 | 84% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $496.5k | 12,102 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $9.7m | 236,034 | 16% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Rubric Capital Management | 3.2% | $20.2m |
How has hedge fund ownership of INDV changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $283.9m |
| Q1 2026 | 7 | $300.3m |
Counts every tracked manager that disclosed INDV in that quarter's filing, including managers that have since stopped filing.